Medical News

RSS

FDA undecided on safety guidelines for hydroquinone use

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the US market for physician-dispensed cosmeceutical pigment control products will experience considerable growth in sales over the next five years. MRG's US Markets for Physician-Dispensed Cosmeceuticals 2009 report finds, however, that product safety issues involving hydroquinone, the active ingredient in many pigment control products, have led the Food and Drug Administration (FDA) to second guess the use of the compound in such products.

8 Sep 2009

Valentx raises funds to develop less-invasive treatment for morbid obesity

ValenTx, Inc., announced today the closing of a $22 million Series B Preferred Stock financing. The round was led by SV Life Sciences and joined by Covidien Ventures, as well as all the Company’s existing venture capital investors: Sapient Capital, EDF Ventures, Kaiser Permanente Ventures, Affinity Capital Partners, and TGap Ventures.

8 Sep 2009

Powered SAFE Scribe hair replacement technique unveiled at ISHRS meeting

James A. Harris, M.D., director of Hair Sciences Center of Colorado, which specializes in state-of-the-art medical and surgical hair restoration, recently introduced to surgeons around the world his latest advancement in hair replacement, the Powered SAFE Scribe. The product was unveiled to the medical community during the 17th Annual Scientific Meeting of the International Society of Hair Restoration Surgery (ISHRS) held in late July in Amsterdam.

8 Sep 2009

Lab Research announces the signing of three new master services agreements with global companies

LAB Research Inc. ("LAB", "LAB Research" or the "Company"), (TSX: LRI), a Canadian-based global non-clinical contract research organization, today announced that it has entered into three new master services agreements with some of the most important global sponsors for each of the pharmaceutical, biotechnology and agro-chemical industries.

8 Sep 2009

New data fuels disagreements over regional Medicare spending

New data fuels some regional disputes on Medicare spending while some communities create better care and spend less than others. The New York Times reports that "new government data show that Medicare costs per patient in those cities [New York City, Boston] are slightly below the national average when the numbers are adjusted for the cost of living and other factors.

8 Sep 2009

Opexa Therapeutics' ongoing development program for Tovaxin to be presented

Opexa Therapeutics, Inc., a company developing Tovaxin, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced that Neil K. Warma, Opexa’s president and chief executive officer, will deliver a corporate presentation at Rodman & Renshaw’s 11th Annual Healthcare Conference.

8 Sep 2009

Rosetta Genomics and AXA Diagnostics sign exclusive distribution agreement

Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer of microRNA-based molecular diagnostics, and AXA Diagnostics, a privately owned company that markets specialized diagnostic tests, announced today the signing of an exclusive distribution agreement in Italy for Rosetta Genomics’ three currently available diagnostic tests.

8 Sep 2009

EDS signs $8.1 million contract with U.S. DoD Military Health System

EDS, an HP company, today announced it has signed an $8.1 million, 12-month add-on contract with the U.S. Department of Defense (DoD) Military Health System to make technical enhancements to several Defense Health Information Management Systems (DHIMS).

8 Sep 2009

Research to develop new techniques for studying wild and transgenic mice's nervous system

Researchers of the Pablo de Olavide University (Seville) have started different projects based on the study of phenotype techniques in mice and their applicability to the pharmaceutical industry and neurodegenerative medicine.

8 Sep 2009

RIKEN Yokohama Institute to purchase Genetic Analysis Systems from Helicos BioSciences

Helicos BioSciences Corporation (NASDAQ:HLCS) today announced that the RIKEN Yokohama Institute Omics Science Center (OSC) has agreed to purchase four Helicos™ Genetic Analysis Systems. The transaction represents the first multisystem sale of the Helicos system to a large genome center. Shipments are expected to take place in September, with one system remaining in Cambridge to be used in a scientific collaboration between the two parties that began last year.

8 Sep 2009

New book on weight loss and fitness released

Modern American society is filled with easily accessible fatty foods, a growing obesity epidemic and a general lack of healthy living. In his new book, "Lose Weight, Feel Great: How I Lost Over 60lbs. with the Help of a Personal Trainer" (published by AuthorHouse), author Kevin Given tells of his personal struggles with obesity, how he lost over 60 pounds with the help of a personal trainer, and how others can change their lifestyles and bodies as well.

8 Sep 2009

Protalix receives orphan drug designation for prGCD

Protalix BioTherapeutics, Inc. (NYSE-Amex:PLX), announced today that it has received notice from the U.S. Food and Drug Administration (FDA) that the FDA’s Office of Orphan Products Development has granted orphan drug designation to prGCD, the Company’s proprietary plant cell expressed recombinant form of glucocerebrosidase (GCD) for the treatment of Gaucher disease.

8 Sep 2009

Fourth-quarter and fiscal year end 2009 results announced by Palatin Technologies

Palatin Technologies, Inc. (NYSE Amex: PTN) today announced results for its fourth quarter and fiscal year ended June 30, 2009. For the year ended June 30, 2009, total revenues were $11.4 million, compared to $11.5 million for year ended June 30, 2008. Palatin's net loss for the year ended June 30, 2009 was $4.8 million, or $(0.06) per basic and diluted share, compared to a net loss of $14.4 million, or $(0.17) per basic and diluted share, for the year ended June 30, 2008.

8 Sep 2009

BEST bags orders for state-of-the-art synchrotron instrumentation

Bruker Energy & Supercon Technologies, Inc. (BEST) today announced that its subsidiary Bruker ASC GmbH in Bergisch Gladbach, Germany, has been awarded several significant contracts for state-of-the-art synchrotron instrumentation from leading research institutions worldwide.

8 Sep 2009

Shire's assistance helps Gaucher patients manage imiglucerase supply shortage

Shire plc, the global specialty biopharmaceutical company, is committed to doing everything possible to assist Gaucher patients and their physicians during the imiglucerase supply shortage. Shire is pleased to be able to provide velaglucerase alfa well over a year ahead of previously anticipated commercial launch world wide.

8 Sep 2009

Proteostasis Therapeutics to use GeneGo's MetaCore integrated software

GeneGo, Inc., the leading systems biology tools company, announced today that Proteostasis Therapeutics has licensed its data mining and analysis platform, MetaCore. Proteostasis Therapeutics is the first company dedicated to the discovery of novel small molecule therapeutics based upon understanding the body's Proteostasis Network. The Proteostasis Network maintains the body's natural balance of proteins to protect us from numerous diseases.

8 Sep 2009

NanoViricides' drug pipeline to be discussed at NanoBusiness2009

NanoViricides, Inc. (the "Company"), announced today that Anil Diwan, PhD, President of the Company has been asked to present a talk at NanoBusiness2009 - the 8th annual NanoBusiness Conference.

8 Sep 2009

Opexa Therapeutics releases Phase IIb TERMS clinical study results

Opexa Therapeutics, Inc., a company developing Tovaxin, a personalized T-cell immunotherapy for multiple sclerosis (MS), today announced results from further analysis of the double-blind, placebo-controlled, 52-week Phase IIb TERMS clinical study of 150 patients with Relapsing Remitting MS (RRMS).

8 Sep 2009

Working mothers suffer from vision impairment as they age

For working mothers -- the ultimate multitaskers -- seeing clearly is essential to getting the job done. Yet, new research reveals that as they age, changes in their vision are impacting the ability of most moms to perform everyday activities at home and on the job.

8 Sep 2009

Fundraising event to benefit the Centre for Addiction and Mental Health

Tickets are now on sale for the third annual Queen Street Unmasked, a gala fundraiser on Wednesday, Oct. 14 to benefit the Centre for Addiction and Mental Health (CAMH).

8 Sep 2009